Dr. Elhajj received his internal medicine degree from Staten Island University Hospital in Staten Island, New York, and completed his gastroenterology fellowship at SUNY Downstate Medical Center, Brooklyn, New York. Dr Elhajj joined our practice in 2008.
Language(s) spoken: English
- USMLE Step I, 1999
- USMLE Step II, 2000
- USMLE Step III, 2001
- Permanent ECFMG Certificate, 2000
Florida
Publications
Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transplantation Volume 12, Issue 5, Date: May 2006, Pages: 827-830
The development of DE NOVO autoimmune hepatitis (immune-mediated hepatitis) and its effect on outcome in patients with HCV post liver transplantation. Hepatology, Volume 44, Issue S1 (p 414A), Abstract # 606
Abstracts
The development of DE NOVO autoimmune hepatitis (immune-mediated hepatitis) and its effect on outcome in patients with HCV post liver transplantation. Poster presentation – AASLD meeting – Boston October 2006
The Risk of Acute Rejection in Patients Treated with Pegylated Interferon and Ribavirin for Recurrent Hepatitis C Post Liver Transplantation. Poster presentation – Digestive Disease Week – New Orleans May 2004
Improved Efficacy and Tolerability in Treating Post-Transplant HCV Utilizing an Escalating Regimen of Pegylated Interferon a-2a and Ribavirin with Hematopoietic Growth Factors: A Prospective Study. Oral presentation – Digestive Disease Week – New Orleans May 2004
Switching from Peg-Interferon a-2b to an escalating Peg-Interferon a-2a Regimen for recurrent Hepatitis C Post Liver Transplantation may Improve Virological Response and Tolerability. Poster presentation – Digestive Disease Week – New Orleans May 2004
Video(s)
Location(s)
HCA Memorial Office
3627 University Blvd., S., Ste. 705 Jacksonville, 32216
Office: 904.398.7205
Southside Office
4800 Belfort Rd., 2nd/3rd Floor Jacksonville, 32256
Office: 904.398.7205
Fax: 904.396.4047
